Federico Giuseppe Usuelli

Federico Giuseppe Usuelli

Auto-generated profile, based on publicly available information

Federico Giuseppe Usuelli

Humanitas San Pio X, Milan, Italy

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Closed access
PDF file
FUFederico Giuseppe Usuelli
Federico Giuseppe Usuelli
MGMiriam Grassi
Miriam Grassi
CMCamilla Maccario
Camilla Maccario
MVMarco Viganò
Marco Viganò
LLLuciano Lanfranchi
Luciano Lanfranchi
LGLaura de Girolamo
Laura de Girolamo

1 June 2009 in Foot and Ankle Clinics
Verified
Journal Article
Closed access
MDMatthew DeOrio
Matthew DeOrio
MEMelissa Erickson
Melissa Erickson
FUFederico Giuseppe Usuelli
Federico Giuseppe Usuelli
MEMark Easley
Mark Easley

1 October 2017 in European Journal of Radiology
Verified
Journal Article
Closed access
DADomenico Albano
Domenico Albano
CMCarmelo Messina
Carmelo Messina
FUFederico Giuseppe Usuelli
Federico Giuseppe Usuelli
LGLaura De Girolamo
Laura De Girolamo
MGMiriam Grassi
Miriam Grassi
LSLuca Maria Sconfienza
Luca Maria Sconfienza

Verified
Journal Article
Open access
PDF file
RDRiccardo D'Ambrosi
Riccardo D'Ambrosi
FVFederico Valli
Federico Valli
Paola De LucaPaola De Luca
Paola De Luca
NUNicola Ursino
Nicola Ursino
FUFederico Giuseppe Usuelli
Federico Giuseppe Usuelli
Background: This study aims to investigate the clinical and radiological efficacy of three-dimensional acellular scaffolds (MaioRegen) in restoring osteochondral knee defects. Methods: MEDLINE, Scopus, CINAHL, Embase, and Cochrane Databases were searched for articles in which patients were treated with MaioRegen for osteochondral knee defects. Results: A total of 471 patients were included in the study (mean age 34.07 ± 5.28 years). The treatment involved 500 lesions divided as follows: 202 (40.4%) medial femoral condyles, 107 (21.4%) lateral femoral condyles, 28 (5.6%) tibial plateaus, 46 (9.2%) trochleas, 74 (14.8%) patellas, and 43 (8.6%) unspecified femoral condyles. Mean lesion size was 3.6 ± 0.85 cm2. Only four studies reported a follow-up longer than 24 months. Significant clinical improvement has been reported in almost all studies with further improvement up to 5 years after surgery. A total of 59 complications were reported of which 52 (11.1%) experienced minor complications and 7 (1.48%) major complications. A total of 16 (3.39%) failures were reported. Conclusion: This systematic review describes the current available evidence for the treatment of osteochondral knee defects with MaioRegen Osteochondral substitute reporting promising satisfactory and reliable results at mid-term follow-up. A low rate of complications and failure was reported, confirming the safety of this scaffold. Considering the low level of evidence of the study included in the review, this data does not support the superiority of the Maioregen in terms of clinical improvement at follow-up compared to conservative treatment or other cartilage techniques.

12 September 2016 in Knee Surgery, Sports Traumatology, Arthroscopy
Verified
Journal Article
Open access
PDF file
FUFederico Giuseppe Usuelli
Federico Giuseppe Usuelli
RDRiccardo D’aMbrosi
Riccardo D’aMbrosi
CMCamilla Maccario
Camilla Maccario
MBMichele Boga
Michele Boga
LGLaura de Girolamo
Laura de Girolamo
Autologous Matrix-Induced Chondrogenesis (AMIC®) is known to provide satisfactory clinical results for the treatment of knee, hip, and ankle cartilage lesions. The purpose of this study was to evaluate clinical and radiological outcomes of patients treated with a new all-arthroscopic AMIC® (AT-AMIC®) technique with autologous bone graft for talar osteochondral defects at a follow-up of 24 months. Twenty patients underwent the AT-AMIC® procedure and autologous bone graft for type III and IV talar osteochondral lesions. Patients were evaluated pre-operatively and at 6, 12, and 24 months post-operatively using the American Orthopedic Foot and Ankle Society (AOFAS) score, the visual analog scale, and the SF-12 (Short Form-12). Radiological assessment included computed tomography (CT), magnetic resonance imaging (MRI), and magnetic resonance observation of cartilage repair tissue (MOCART). All scores significantly improved (p < 0.05) with respect to pre-operative values after 6 months. Further improvements were detected at 24 months (AOFAS, from 57.1 ± 14.9 before surgery to 86.6 ± 10.9 after 24 months; VAS, from 8.1 ± 1.4 to 2.5 ± 2.2; SF-12, from 29.9 ± 4.1 to 48.5 ± 6.9 and from 43.8 ± 2.9 to 53.1 ± 3.9, respectively, for Physical and Mental component score). Lesion area significantly reduced from 111.1 ± 43.2 mm2 pre-operatively to 76.9 ± 38.1 mm2 (p < 0.05) at final follow-up as assessed by CT, and from 154.1 ± 93.6 to 94.3 ± 61.3 mm2 (p < 0.05) as assessed by MRI. The mean MOCART score was 42.8 ± 23.5 points and 50.9 ± 24.9 points, respectively, at 12 and 24 months after surgery (p < 0.05). AT-AMIC® with autologous bone grafting has proven to be a safe and effective minimal invasive technique, able to rapidly and significantly improve pain, function, and radiological healing of osteochondral talar lesions, with progressive further improvements up to 24 months. Orthopedic surgeons specialized in foot and ankle surgery should adopt the AT-AMIC® technique for the treatment of osteochondral talar lesions, which proved to be effective and minimally invasive, avoiding malleolar osteotomy with a low risk of complications. IV.

21 September 2011 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
LLL. Daniel Latt
L. Daniel Latt
RGRichard R. Glisson
Richard R. Glisson
HMHarvey E. Montijo
Harvey E. Montijo
FUFederico G. Usuelli
Federico G. Usuelli
MEMark E. Easley
Mark E. Easley
Background: Osteochondral allograft transplantation is technically demanding. It is not always possible to place the surface of the graft perfectly flush with the surrounding cartilage. One must often choose between placing at least some portion of the surface of the graft slightly elevated or recessed. The effect of this choice on joint contact pressure is unknown.